Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Barbara Senk
Genetic Polymorphisms in Aquaporin 1 as Risk Factors for Malignant Mesothelioma and Biomarkers of Response to Cisplatin Treatment
Radiology and Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Related publications
Genetic Polymorphisms and Ovarian Cancer Risk and Response to Paclitaxel/Cisplatin Chemotherapy
Hereditary Cancer in Clinical Practice
Oncology
Genetics
MicroRNAs as Potential Biomarkers in Malignant Pleural Mesothelioma
Current Biomarker Findings
Biochemistry
Clinical Biochemistry
Discovery of New Biomarkers for Malignant Mesothelioma
Current Pulmonology Reports
Genetic and Modifiable Risk Factors Contributing to Cisplatin-Induced Toxicities
Clinical Cancer Research
Cancer Research
Oncology
Cisplatin-Induced GADD34 Upregulation Potentiates Oncolytic Viral Therapy in the Treatment of Malignant Pleural Mesothelioma
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
The Influence of Genetic Variability on the Risk of Developing Malignant Mesothelioma
Radiology and Oncology
Nuclear Medicine
Radiology
Imaging
Oncology
Enhanced Cisplatin Response With Histone Acetyl Transferase Inhibitor, Anacardic Acid, in Malignant Pleural Mesothelioma Cell Line
Turkiye Klinikleri Journal of Medical Sciences
Medicine
Multimodality Treatment of Malignant Pleural Mesothelioma
F1000Research
Genetics
Molecular Biology
Pharmacology
Biochemistry
Microbiology
Immunology
Medicine
Toxicology
Pharmaceutics
A Retrospective Study of Palliative Cisplatin-Based Doublet Chemotherapy for Malignant Pleural Mesothelioma
Cancer and Clinical Oncology